Atorvastatin Calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Scope of the Report:
This report focuses on the Atorvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
The worldwide market for Atorvastatin Calcium is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 230 million US$ in 2023, from 160 million US$ in 2017, according to a new GIR (Global Info Research) study.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-atorvastatin-calcium-2023-111
Market Segment by Manufacturers, this report covers
- Pfizer
- DSM Sinochem Pharmaceuticals
- Cadila Pharmaceuticals
- Sun Pharmaceutical Industries
- Dr. Reddy’s
- Morepen
- Teva Pharmaceutical Industries
- Apotex Pharmachem
- Sandoz Inc
- Mylan Pharmaceuticals Inc.
- Kremers Urban Pharmaceuticals Inc.
- ScieGen Pharmaceuticals, Inc.
- Zheijang Neo-Dankon Pharmaceutical
- Ningbo Menovo Pharmaceuticals Group
- Jialin Pharmaceutical
- Topfond
- Zhejiang Hisun Pharmacutical
- Zhejiang Hongyuan Pharmaceutical
- Hubei Yitai Pharmaceutical
- Jiangsu Hengrui Medicine
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Chemical Synthesis
- Biocatalysis
- Others
Market Segment by Applications, can be divided into
- Tablet (Including Dispersible Tablet and General Tablet)
- Capsule
- Others
There are 15 Chapters to deeply display the global Atorvastatin Calcium market.
- Chapter 1, to describe Atorvastatin Calcium Introduction, product scope, market overview, market opportunities, market risk, market driving force;
- Chapter 2, to analyze the top manufacturers of Atorvastatin Calcium, with sales, revenue, and price of Atorvastatin Calcium, in 2016 and 2017;
- Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
- Chapter 4, to show the global market by regions, with sales, revenue and market share of Atorvastatin Calcium, for each region, from 2013 to 2018;
- Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
- Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
- Chapter 12, Atorvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
- Chapter 13, 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-atorvastatin-calcium-2023-111
No comments:
Post a Comment